Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPulmonologyUnitedHealthcare Bronchial Policy Update | OpenPay…
    Ask Trek AI about this page
    CurrentUnitedHealthcare Community PlanPolicy CS014NE.Q

    Bronchial Thermoplasty (for Nebraska Only)

    Customize your policy alerts

    Sign up for UnitedHealthcare Policy CS014NE.Q alerts

    Get alerted when Policy CS014NE.Q changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of bronchial thermoplasty for asthma for UnitedHealthcare Community Plan members in Nebraska. The procedure is considered unproven and not medically necessary because evidence is insufficient.

    Policy Summary
    PayerUnitedHealthcare Community Plan
    PolicyBronchial Thermoplasty (for Nebraska Only)
    Policy CodePolicy CS014NE.Q
    Change TypeSupporting information updateno material coverage change
    Effective DateOctober 1, 2026
    Next Review DateN/A
    Key ActionDo not submit bronchial thermoplasty for coverage because it is considered unproven and not medically necessary.
    SourceLink
    POLICY UPDATE CHANGES

    The Clinical Evidence and References sections were updated with current information.

    Not medically necessaryCoverage determination
    Nebraska onlyGeographic application
    3 visitsTypical treatment schedule
    FEV1 <60%Predicted FEV1 threshold

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Bronchial Thermoplasty Coverage Criteria

    Bronchial thermoplasty for asthma

    Coverage determination:

    Coverage determination: Bronchial thermoplasty is unproven and not medically necessary for treating asthma due to insufficient evidence of efficacy.

    The policy does not provide covered clinical criteria or an exception pathway.

    Bronchial thermoplasty is not medically necessary for treating asthma because evidence of efficacy is insufficient. The procedure is therefore considered unproven.

    Applicable and Supporting Codes

    Applicable CPT CodesCPT
    31661Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial thermoplasty, 2 or more lobes
    FDA Product CodeFDA
    OOYFDA product code for bronchial thermoplasty systems
    Predicted FEV1
    Predicted FEV1 thresholdLess than 60% of predicted value
    Study populationIndividuals with an FEV1 of less than 60% predicted were excluded from the pivotal sham-controlled study
    Further studyThe effects of bronchial thermoplasty in individuals with severe obstructive asthma and FEV1 less than 60% of predicted value require further study

    Provider Impact and Coverage Decisions

    Denial Risk

    Unproven and not medically necessary

    Bronchial thermoplasty for treating asthma is denied because it is considered unproven and not medically necessary due to insufficient evidence of efficacy.

    Denial Risk

    FDA approval alone does not establish coverage

    FDA approval alone is not a basis for coverage. The FDA information is provided for informational purposes only and does not establish coverage for bronchial thermoplasty.

    Asthma Background

    Asthma is a heterogeneous disease generally characterized by chronic airway inflammation, variable symptoms, and expiratory airflow limitation.

    Bronchial Thermoplasty

    Bronchial Thermoplasty
    ProcedureMinimally invasive procedure intended to treat adults with severe, persistent asthma that is not well controlled with medications
    Energy usedThermal radiofrequency energy
    Intended effectReduce airway smooth muscle mass and responsiveness
    Policy Summary
    PayerUnitedHealthcare Community Plan
    PolicyBronchial Thermoplasty (for Nebraska Only)
    Policy CodePolicy CS014NE.Q
    Change TypeSupporting information updateno material coverage change
    Effective DateOctober 1, 2026
    Next Review DateN/A
    Key ActionDo not submit bronchial thermoplasty for coverage because it is considered unproven and not medically necessary.
    SourceLink
    On This Page
    Bronchial Thermoplasty Coverage CriteriaApplicable and Supporting CodesProvider Impact and Coverage DecisionsAsthma BackgroundBronchial Thermoplasty